Atlas Trials

Optimizing Pazopanib Exposure in RCC Patients

Clinical trial NCT02089802 · TERMINATED

Trial details

NCT number
NCT02089802
Sponsor
Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Start date
2014-02-25
Primary completion
2016-03-22
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.